1. Home
  2. AMBO vs PULM Comparison

AMBO vs PULM Comparison

Compare AMBO & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

BUY

Current Price

$1.83

Market Cap

5.9M

Sector

Real Estate

ML Signal

BUY

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$1.48

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMBO
PULM
Founded
2000
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.2M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
AMBO
PULM
Price
$1.83
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
★ 46.4K
Earning Date
11-11-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 337.04
46.18
EPS
★ 0.00
N/A
Revenue
★ $9,469,000.00
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$67.27
P/E Ratio
$379.59
★ N/A
Revenue Growth
0.82
★ 5069.93
52 Week Low
$1.47
$1.16
52 Week High
$6.75
$5.24

Technical Indicators

Market Signals
Indicator
AMBO
PULM
Relative Strength Index (RSI) 36.20 48.60
Support Level $1.69 $1.44
Resistance Level $2.31 $1.55
Average True Range (ATR) 0.07 0.10
MACD -0.02 0.00
Stochastic Oscillator 0.00 37.87

Price Performance

Historical Comparison
AMBO
PULM

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: